Market Outlook
The global Latent Tuberculosis Infection (LTBI) Testing market size was valued at USD 1436.4 million in 2022 and is forecast to a readjusted size of USD 2043.9 million by 2029 with a CAGR of 5.2% during review period.
Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.
The detection industry of latent tuberculosis infection (LTBI) can be subdivided into several parts: tuberculin skin test (TST), interferon release test (IGRA), etc. Globally, there are mainly Qiagen, Oxford Immunotec, Sanofi, etc.
Diagnosing and treating latent tuberculosis infection (LTBI) is an important strategy recognized by the World Health Organization to accelerate the decline of global tuberculosis and achieve the elimination of tuberculosis. Latent tuberculosis infection (LTBI) refers to the state of continuous immune response to the stimulation of Mycobacterium tuberculosis antigen in the absence of clinical evidence of active tuberculosis (TB). The diagnosis and treatment of long-term tuberculosis is very important for tuberculosis, especially for high-risk groups. Tuberculin skin tests (TST) and interferon release tests (IGRAs) were used to diagnose LTBI.
This report is a detailed and comprehensive analysis for global Latent Tuberculosis Infection (LTBI) Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Latent Tuberculosis Infection (LTBI) Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Latent Tuberculosis Infection (LTBI) Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Latent Tuberculosis Infection (LTBI) Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Latent Tuberculosis Infection (LTBI) Testing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Latent Tuberculosis Infection (LTBI) Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Latent Tuberculosis Infection (LTBI) Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Qiagen
Sanofi
Oxford Immunotec
Thermo Fisher Scientific
Par Sterile
Bio-Rad Laboratories
Segmentation By Type
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Segmentation By Application
Hospitals and Clinics
Diagnostic Laboratories
Others
Segmentation By Region
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the LTBI Testing Market in 2025?
The LTBI testing market is driven by increasing awareness of tuberculosis (TB), rising global health concerns, and an emphasis on early detection and prevention. Advancements in diagnostic technologies, such as molecular tests and interferon-gamma release assays (IGRAs), will also enhance the accuracy and efficiency of testing.
How do weaknesses affect the LTBI Testing Market?
One of the main weaknesses is the high cost of diagnostic tests, particularly in low- and middle-income countries, which can limit widespread access. There is also a challenge in the interpretation of test results, as false positives or negatives could lead to unnecessary treatments or missed diagnoses, hindering the market's growth.
What are the opportunities for growth in the LTBI Testing Market?
There is an opportunity to expand access to LTBI testing in underdeveloped regions through innovative, cost-effective, point-of-care testing solutions. Additionally, the rising global burden of TB and increased focus on preventive healthcare will drive demand. Collaborations between governments, healthcare providers, and organizations can further improve testing infrastructure.
What are the potential threats to the LTBI Testing Market?
A significant threat is the competition from alternative diagnostic methods that might be more cost-effective or easier to use. Regulatory challenges and the possibility of misdiagnosis can also reduce market growth. Moreover, any lack of funding or policy support for TB control programs may hinder the development and availability of LTBI tests.
Market PESTEL Analysis
How do political factors impact the LTBI Testing Market in 2025?
Political factors, such as government healthcare policies and funding for TB control programs, play a crucial role. Support for public health initiatives, subsidies for diagnostic technologies, and international collaborations can drive market growth. Political instability or lack of healthcare funding in certain regions, however, may hinder the market.
How do economic factors influence the LTBI Testing Market?
Economic factors, including GDP growth, healthcare expenditure, and affordability of diagnostic tests, directly affect the market. In high-income countries, there is more investment in advanced LTBI testing solutions. However, in low- and middle-income countries, economic constraints may limit the adoption of costly diagnostic tests, affecting the market potential.
How do social factors shape the LTBI Testing Market?
Social awareness of TB and its prevention is crucial for the LTBI testing market. Increased health awareness campaigns, community outreach, and education about latent TB infection (LTBI) encourage testing. Stigma associated with TB in certain cultures can also affect the willingness of individuals to undergo testing, potentially limiting market growth.
How do technological factors impact the LTBI Testing Market?
Advancements in diagnostic technology, such as faster, more accurate molecular tests and point-of-care testing solutions, are critical drivers of the LTBI testing market. Innovation in test formats and digital health platforms can improve test accessibility, efficiency, and patient outcomes, boosting market growth.
How do environmental factors influence the LTBI Testing Market?
Environmental factors like the prevalence of TB in specific regions and the quality of healthcare infrastructure influence testing demand. In areas with higher TB rates, especially in developing nations, there is a greater need for effective LTBI detection and testing. Environmental conditions, such as overcrowded living conditions, can also increase the transmission risk, encouraging testing.
How do legal factors affect the LTBI Testing Market?
Legal regulations surrounding healthcare standards, diagnostic approval, and ethical practices can impact the LTBI testing market. Strict regulations can slow down the approval and adoption of new testing technologies, while a lack of regulatory frameworks in some regions may affect the reliability of tests. Additionally, laws regarding patient privacy and data protection must be considered in testing procedures.
Market SIPOC Analysis
Who are the suppliers in the LTBI Testing Market?
Suppliers in the LTBI testing market include manufacturers of diagnostic kits, reagents, laboratory equipment, and molecular test technologies. These suppliers also include research organizations and healthcare institutions that develop and produce new testing solutions.
What are the inputs for the LTBI Testing Market?
The key inputs for the LTBI testing market include raw materials for test kits (antibodies, chemicals, and reagents), skilled labor for research and development, regulatory approvals, and technological advancements in diagnostics such as PCR and IGRA tests.
Who are the process owners in the LTBI Testing Market?
Process owners are typically healthcare organizations, diagnostic laboratories, public health agencies, and healthcare providers who oversee the implementation and delivery of LTBI testing services. They are responsible for ensuring proper testing procedures and accurate diagnosis.
What are the outputs of the LTBI Testing Market?
The outputs include accurate test results for latent tuberculosis infection, diagnostic reports, and recommendations for preventive treatment. These outputs ultimately contribute to improved public health, early detection, and TB control efforts.
Who are the customers in the LTBI Testing Market?
Customers in the LTBI testing market include healthcare facilities (hospitals, clinics, and diagnostic centers), government health agencies, patients seeking diagnosis and treatment, as well as international organizations involved in TB control and prevention programs.
Market Porter's Five Forces
How does the threat of new entrants affect the LTBI Testing Market in 2025?
The threat of new entrants is moderate. While the LTBI testing market requires significant investment in research, development, and regulatory approval, the increasing demand for TB diagnostics and advancements in technology may encourage new companies to enter. However, barriers such as high costs and established competition from large diagnostic firms reduce the likelihood of new competitors disrupting the market significantly.
How does the bargaining power of suppliers influence the LTBI Testing Market?
The bargaining power of suppliers is moderate. Suppliers of critical raw materials, such as reagents, antibodies, and testing equipment, hold some leverage due to the specialized nature of the products. However, the growing number of suppliers and advancements in manufacturing processes have somewhat reduced supplier power, making it easier for companies to source materials from multiple suppliers.
How does the bargaining power of buyers affect the LTBI Testing Market?
The bargaining power of buyers is moderate to high. Healthcare organizations, governments, and international health organizations have considerable bargaining power, especially when purchasing diagnostic tests in bulk. They are driven by cost-effectiveness and the availability of multiple testing options, allowing them to negotiate better prices. However, the demand for accurate, reliable tests keeps buyers invested in quality, limiting their power in some cases.
How does the threat of substitute products impact the LTBI Testing Market?
The threat of substitutes is moderate. While traditional diagnostic methods like the tuberculin skin test (TST) are still in use, newer technologies such as molecular diagnostics and blood tests (e.g., IGRA) offer improved accuracy and convenience. However, no single alternative has fully replaced LTBI testing, and the market remains dependent on established methods. The growing need for early TB detection could keep substitutes at bay for now.
How does the intensity of competitive rivalry affect the LTBI Testing Market?
The intensity of competitive rivalry is high. The LTBI testing market is dominated by a few major players, but numerous smaller companies are emerging with innovative diagnostic technologies. Intense competition exists among firms aiming to offer more accurate, faster, and cost-effective testing solutions. As the global need for TB control increases, competition in pricing, technology, and market share will intensify.
Market Upstream Analysis
What are the key raw materials involved in the LTBI Testing Market?
The key raw materials include antibodies, chemicals, reagents, and biomaterials used in diagnostic kits. Additionally, raw materials for developing molecular testing platforms like PCR and IGRA assays are essential in creating accurate and reliable tests.
How do research and development (R&D) efforts impact the LTBI Testing Market?
R&D efforts are crucial in driving innovation and improving the accuracy, speed, and cost-effectiveness of LTBI tests. Advances in diagnostic technologies, such as next-generation sequencing and molecular diagnostics, require ongoing research to refine existing tests and develop new solutions that can meet global healthcare needs.
What role do regulatory requirements play in the LTBI Testing Market?
Regulatory requirements significantly impact the upstream activities in the LTBI testing market. Approval from regulatory bodies like the FDA, EMA, and WHO ensures that diagnostic tests meet safety and efficacy standards. These regulations can delay product launches but are essential for maintaining quality and ensuring the reliability of tests.
How do suppliers of diagnostic technology influence the LTBI Testing Market?
Suppliers of diagnostic technologies, including manufacturers of PCR machines, blood test kits, and laboratory instruments, play a pivotal role in the upstream supply chain. The availability, cost, and quality of these technologies affect the production of LTBI tests and influence the market's growth and development.
How does the cost of raw materials affect the LTBI Testing Market?
The cost of raw materials directly impacts the production cost of LTBI diagnostic tests. Fluctuations in the price of key ingredients, such as reagents or specialized equipment, can affect the overall pricing of tests. If raw material costs increase, manufacturers may face pressure to either raise test prices or find ways to absorb the additional cost, impacting market dynamics.
Market Midstream Analysis
What role do manufacturers play in the LTBI Testing Market?
Manufacturers are responsible for producing the diagnostic kits, reagents, and testing equipment used in LTBI testing. They focus on scaling production, ensuring product quality, and meeting regulatory standards. Their efficiency in production and the ability to innovate new technologies will shape the market's growth in 2025.
How does distribution impact the LTBI Testing Market?
Distribution is critical in ensuring that LTBI diagnostic tests reach healthcare providers, clinics, and diagnostic centers. Efficient logistics, including cold chain management for sensitive tests, and strong distribution networks are key for making testing widely available. Poor distribution networks in developing regions can limit market penetration.
What is the significance of healthcare providers in the LTBI Testing Market?
Healthcare providers, including hospitals, clinics, and public health organizations, are pivotal in administering LTBI tests. They act as the primary channel for reaching patients, interpreting test results, and recommending treatments. Their adoption of new diagnostic technologies directly impacts the market’s success and growth.
How do pricing strategies affect the LTBI Testing Market?
Pricing strategies play a vital role in making LTBI tests accessible to various regions and healthcare systems. Competitive pricing, tiered pricing models for different income levels, and cost-effective testing solutions can drive adoption, particularly in low-resource settings. High prices may limit market growth, especially in underdeveloped countries.
How does the training and support for diagnostic use affect the LTBI Testing Market?
Training and support for healthcare professionals are essential for ensuring proper use of LTBI tests. Without adequate training, there could be issues with inaccurate test administration or misinterpretation of results. Manufacturers and distributors that provide training programs and support services enhance the market's value by improving the accuracy and reliability of testing.
Market Downstream Analysis
How do patients influence the LTBI Testing Market?
Patients play a central role in driving demand for LTBI testing, particularly as awareness of TB and its risks increases. Their willingness to undergo testing, often influenced by healthcare providers’ recommendations, directly impacts market adoption. Public health campaigns that educate the public about latent tuberculosis also encourage patient participation.
How do healthcare systems and insurance providers impact the LTBI Testing Market?
Healthcare systems and insurance providers significantly influence the LTBI testing market by determining reimbursement policies, coverage, and access to testing. If insurance companies cover the cost of testing or if government health programs include LTBI screening, it can boost test adoption and facilitate broader testing programs across different regions.
What role does public health policy play in the LTBI Testing Market?
Public health policy plays a crucial role in shaping the LTBI testing landscape. National TB control strategies and global health initiatives, such as the World Health Organization’s efforts, drive the implementation of routine LTBI testing, especially in high-risk populations. Strong policies promote widespread testing, ensuring better control and prevention of tuberculosis.
How does the healthcare infrastructure impact the LTBI Testing Market?
The quality and accessibility of healthcare infrastructure directly affect the reach and effectiveness of LTBI testing. In countries with well-developed healthcare systems, there is greater capacity to implement large-scale screening programs. In contrast, poor healthcare infrastructure or limited access to testing facilities in low-income regions may hinder the market’s growth.
How does customer feedback and satisfaction impact the LTBI Testing Market?
Customer feedback and satisfaction, particularly from healthcare providers and patients, influence product development and market strategies. Positive experiences with accurate and quick diagnostic tests lead to greater trust and wider usage. Negative feedback, such as concerns over test reliability or high costs, can prompt manufacturers to improve their products, ultimately shaping market trends.
Chapter 1, to describe Latent Tuberculosis Infection (LTBI) Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Latent Tuberculosis Infection (LTBI) Testing, with revenue, gross margin and global market share of Latent Tuberculosis Infection (LTBI) Testing from 2018 to 2023.
Chapter 3, the Latent Tuberculosis Infection (LTBI) Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Latent Tuberculosis Infection (LTBI) Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Latent Tuberculosis Infection (LTBI) Testing.
Chapter 13, to describe Latent Tuberculosis Infection (LTBI) Testing research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Latent Tuberculosis Infection (LTBI) Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Latent Tuberculosis Infection (LTBI) Testing by Type
1.3.1 Overview: Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Type in 2022
1.3.3 Tuberculin Skin Test (TST)
1.3.4 Interferon Gamma Released Assay (IGRA)
1.4 Global Latent Tuberculosis Infection (LTBI) Testing Market by Application
1.4.1 Overview: Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals and Clinics
1.4.3 Diagnostic Laboratories
1.4.4 Others
1.5 Global Latent Tuberculosis Infection (LTBI) Testing Market Size & Forecast
1.6 Global Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast by Region
1.6.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region, (2018-2029)
1.6.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2018-2029)
1.6.4 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2018-2029)
1.6.6 South America Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Qiagen
2.1.1 Qiagen Details
2.1.2 Qiagen Major Business
2.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.1.4 Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Qiagen Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.2.4 Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 Oxford Immunotec
2.3.1 Oxford Immunotec Details
2.3.2 Oxford Immunotec Major Business
2.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.3.4 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Oxford Immunotec Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.4.4 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 Par Sterile
2.5.1 Par Sterile Details
2.5.2 Par Sterile Major Business
2.5.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.5.4 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Par Sterile Recent Developments and Future Plans
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business
2.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.6.4 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bio-Rad Laboratories Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Latent Tuberculosis Infection (LTBI) Testing by Company Revenue
3.2.2 Top 3 Latent Tuberculosis Infection (LTBI) Testing Players Market Share in 2022
3.2.3 Top 6 Latent Tuberculosis Infection (LTBI) Testing Players Market Share in 2022
3.3 Latent Tuberculosis Infection (LTBI) Testing Market: Overall Company Footprint Analysis
3.3.1 Latent Tuberculosis Infection (LTBI) Testing Market: Region Footprint
3.3.2 Latent Tuberculosis Infection (LTBI) Testing Market: Company Product Type Footprint
3.3.3 Latent Tuberculosis Infection (LTBI) Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value and Market Share by Type (2018-2023)
4.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Application (2018-2023)
5.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Application (2024-2029)
6 North America
6.1 North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2018-2029)
6.2 North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2018-2029)
6.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
6.3.1 North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2018-2029)
6.3.2 United States Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
6.3.3 Canada Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
6.3.4 Mexico Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2018-2029)
7.2 Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2018-2029)
7.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
7.3.1 Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2018-2029)
7.3.2 Germany Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
7.3.3 France Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
7.3.5 Russia Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
7.3.6 Italy Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region
8.3.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Region (2018-2029)
8.3.2 China Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
8.3.3 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
8.3.4 South Korea Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
8.3.5 India Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
8.3.7 Australia Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
9 South America
9.1 South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2018-2029)
9.2 South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2018-2029)
9.3 South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
9.3.1 South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2018-2029)
9.3.2 Brazil Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
9.3.3 Argentina Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
10.3.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2018-2029)
10.3.2 Turkey Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
10.3.4 UAE Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Latent Tuberculosis Infection (LTBI) Testing Market Drivers
11.2 Latent Tuberculosis Infection (LTBI) Testing Market Restraints
11.3 Latent Tuberculosis Infection (LTBI) Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Latent Tuberculosis Infection (LTBI) Testing Industry Chain
12.2 Latent Tuberculosis Infection (LTBI) Testing Upstream Analysis
12.3 Latent Tuberculosis Infection (LTBI) Testing Midstream Analysis
12.4 Latent Tuberculosis Infection (LTBI) Testing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Qiagen Company Information, Head Office, and Major Competitors
Table 6. Qiagen Major Business
Table 7. Qiagen Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 8. Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Qiagen Recent Developments and Future Plans
Table 10. Sanofi Company Information, Head Office, and Major Competitors
Table 11. Sanofi Major Business
Table 12. Sanofi Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 13. Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Sanofi Recent Developments and Future Plans
Table 15. Oxford Immunotec Company Information, Head Office, and Major Competitors
Table 16. Oxford Immunotec Major Business
Table 17. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 18. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Oxford Immunotec Recent Developments and Future Plans
Table 20. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 21. Thermo Fisher Scientific Major Business
Table 22. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 23. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Thermo Fisher Scientific Recent Developments and Future Plans
Table 25. Par Sterile Company Information, Head Office, and Major Competitors
Table 26. Par Sterile Major Business
Table 27. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 28. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Par Sterile Recent Developments and Future Plans
Table 30. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 31. Bio-Rad Laboratories Major Business
Table 32. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 33. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Bio-Rad Laboratories Recent Developments and Future Plans
Table 35. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Players (2018-2023)
Table 36. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Players (2018-2023)
Table 37. Breakdown of Latent Tuberculosis Infection (LTBI) Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 38. Market Position of Players in Latent Tuberculosis Infection (LTBI) Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 39. Head Office of Key Latent Tuberculosis Infection (LTBI) Testing Players
Table 40. Latent Tuberculosis Infection (LTBI) Testing Market: Company Product Type Footprint
Table 41. Latent Tuberculosis Infection (LTBI) Testing Market: Company Product Application Footprint
Table 42. Latent Tuberculosis Infection (LTBI) Testing New Market Entrants and Barriers to Market Entry
Table 43. Latent Tuberculosis Infection (LTBI) Testing Mergers, Acquisition, Agreements, and Collaborations
Table 44. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value (USD Million) by Type (2018-2023)
Table 45. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Share by Type (2018-2023)
Table 46. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Forecast by Type (2024-2029)
Table 47. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2018-2023)
Table 48. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Forecast by Application (2024-2029)
Table 49. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 50. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 51. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 52. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 53. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 54. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 55. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 58. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 59. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 60. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 61. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 62. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 63. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 64. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 65. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 66. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 67. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 68. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 69. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 70. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 71. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 72. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 74. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 75. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 76. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 77. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 78. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 79. Latent Tuberculosis Infection (LTBI) Testing Raw Material
Table 80. Key Suppliers of Latent Tuberculosis Infection (LTBI) Testing Raw Materials
List of Figures
Figure 1. Latent Tuberculosis Infection (LTBI) Testing Picture
Figure 2. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Type in 2022
Figure 4. Tuberculin Skin Test (TST)
Figure 5. Interferon Gamma Released Assay (IGRA)
Figure 6. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Application in 2022
Figure 8. Hospitals and Clinics Picture
Figure 9. Diagnostic Laboratories Picture
Figure 10. Others Picture
Figure 11. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Latent Tuberculosis Infection (LTBI) Testing Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Region in 2022
Figure 16. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Players in 2022
Figure 22. Latent Tuberculosis Infection (LTBI) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Latent Tuberculosis Infection (LTBI) Testing Market Share in 2022
Figure 24. Global Top 6 Players Latent Tuberculosis Infection (LTBI) Testing Market Share in 2022
Figure 25. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Share by Type (2018-2023)
Figure 26. Global Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Type (2024-2029)
Figure 27. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Share by Application (2018-2023)
Figure 28. Global Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Application (2024-2029)
Figure 29. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 39. France Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Region (2018-2029)
Figure 46. China Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 49. India Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2018-2029) & (USD Million)
Figure 63. Latent Tuberculosis Infection (LTBI) Testing Market Drivers
Figure 64. Latent Tuberculosis Infection (LTBI) Testing Market Restraints
Figure 65. Latent Tuberculosis Infection (LTBI) Testing Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Latent Tuberculosis Infection (LTBI) Testing in 2022
Figure 68. Manufacturing Process Analysis of Latent Tuberculosis Infection (LTBI) Testing
Figure 69. Latent Tuberculosis Infection (LTBI) Testing Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
